Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.950
+0.010 (0.34%)
Nov 21, 2024, 1:46 PM EST - Market open
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $31.76 million as of November 21, 2024. Its market cap has increased by 1.80% in one year.
Market Cap
31.76M
Enterprise Value
3.89M
1-Year Change
1.80%
Ranking
Category
Stock Price
$2.95
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $31.76M, an increase of 4.70%. That is a compound annual growth rate of 1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 31.65M | -31.97% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 32.87M |
| Citius Pharmaceuticals | 32.82M |
| HOOKIPA Pharma | 32.79M |
| Passage Bio | 31.73M |
| Eterna Therapeutics | 31.58M |
| Curis | 31.00M |
| BioVie | 30.50M |
| Impact BioMedical | 30.49M |